These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 33895327)
1. Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders. Roseboom PH; Mueller SAL; Oler JA; Fox AS; Riedel MK; Elam VR; Olsen ME; Gomez JL; Boehm MA; DiFilippo AH; Christian BT; Michaelides M; Kalin NH Mol Ther; 2021 Dec; 29(12):3484-3497. PubMed ID: 33895327 [TBL] [Abstract][Full Text] [Related]
2. DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates. Mueller SAL; Oler JA; Roseboom PH; Aggarwal N; Kenwood MM; Riedel MK; Elam VR; Olsen ME; DiFilippo AH; Christian BT; Hu X; Galvan A; Boehm MA; Michaelides M; Kalin NH bioRxiv; 2023 Jun; ():. PubMed ID: 37333300 [TBL] [Abstract][Full Text] [Related]
3. DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates. Mueller SAL; Oler JA; Roseboom PH; Aggarwal N; Kenwood MM; Riedel MK; Elam VR; Olsen ME; DiFilippo AH; Christian BT; Hu X; Galvan A; Boehm MA; Michaelides M; Kalin NH Curr Res Neurobiol; 2023; 5():100111. PubMed ID: 38020807 [TBL] [Abstract][Full Text] [Related]
4. Chemogenetic Inhibition of the Amygdala Modulates Emotional Behavior Expression in Infant Rhesus Monkeys. Raper J; Murphy L; Richardson R; Romm Z; Kovacs-Balint Z; Payne C; Galvan A eNeuro; 2019; 6(5):. PubMed ID: 31541000 [TBL] [Abstract][Full Text] [Related]
5. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys. Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415 [TBL] [Abstract][Full Text] [Related]
6. Chronic Behavioral Manipulation via Orally Delivered Chemogenetic Actuator in Macaques. Oyama K; Hori Y; Nagai Y; Miyakawa N; Mimura K; Hirabayashi T; Inoue KI; Takada M; Higuchi M; Minamimoto T J Neurosci; 2022 Mar; 42(12):2552-2561. PubMed ID: 35110390 [TBL] [Abstract][Full Text] [Related]
7. In vivo electrophysiological validation of DREADD-based modulation of pallidal neurons in the non-human primate. Deffains M; Nguyen TH; Orignac H; Biendon N; Dovero S; Bezard E; Boraud T Eur J Neurosci; 2021 Apr; 53(7):2192-2204. PubMed ID: 32306446 [TBL] [Abstract][Full Text] [Related]
8. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. Nagai Y; Miyakawa N; Takuwa H; Hori Y; Oyama K; Ji B; Takahashi M; Huang XP; Slocum ST; DiBerto JF; Xiong Y; Urushihata T; Hirabayashi T; Fujimoto A; Mimura K; English JG; Liu J; Inoue KI; Kumata K; Seki C; Ono M; Shimojo M; Zhang MR; Tomita Y; Nakahara J; Suhara T; Takada M; Higuchi M; Jin J; Roth BL; Minamimoto T Nat Neurosci; 2020 Sep; 23(9):1157-1167. PubMed ID: 32632286 [TBL] [Abstract][Full Text] [Related]
9. [A novel ligand for chemogenetic receptors, Deschloroclozapine, enables rapid and selective modulation of neuronal activity and behavior in living animals]. Nagai Y Nihon Yakurigaku Zasshi; 2022; 157(4):233-237. PubMed ID: 35781451 [TBL] [Abstract][Full Text] [Related]
11. Characterization of DREADD receptor expression and function in rhesus macaques trained to discriminate ethanol. Allen DC; Jimenez VA; Carlson TL; Walter NA; Grant KA; Cuzon Carlson VC Neuropsychopharmacology; 2022 Mar; 47(4):857-865. PubMed ID: 34654906 [TBL] [Abstract][Full Text] [Related]
12. Effect of chemogenetic actuator drugs on prefrontal cortex-dependent working memory in nonhuman primates. Upright NA; Baxter MG Neuropsychopharmacology; 2020 Oct; 45(11):1793-1798. PubMed ID: 32193513 [TBL] [Abstract][Full Text] [Related]
13. Chronic hM4Di-DREADD-Mediated Chemogenetic Inhibition of Forebrain Excitatory Neurons in Postnatal or Juvenile Life Does Not Alter Adult Mood-Related Behavior. Tiwari P; Kapri D; Pradhan A; Balakrishnan A; Chaudhari PR; Vaidya VA eNeuro; 2022; 9(1):. PubMed ID: 35115382 [TBL] [Abstract][Full Text] [Related]
14. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model. Desloovere J; Boon P; Larsen LE; Goossens MG; Delbeke J; Carrette E; Wadman W; Vonck K; Raedt R Neurotherapeutics; 2022 Jan; 19(1):342-351. PubMed ID: 34862591 [TBL] [Abstract][Full Text] [Related]
15. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice? Tran FH; Spears SL; Ahn KJ; Eisch AJ; Yun S Neurosci Lett; 2020 Nov; 739():135432. PubMed ID: 33080350 [TBL] [Abstract][Full Text] [Related]